Genomic biomarker of checkpoint efficacy, highways for precision medicine in lung cancer.
Genomic biomarker of checkpoint efficacy, highways for precision medicine in lung cancer.
Oncotarget. 2018 Nov 27;9(93):36547-36548
Authors: Ghiringhelli F, Truntzer C
PMID: 30564294 [PubMed]
Source: Oncotarget - Category: Cancer & Oncology Tags: Oncotarget Source Type: research